Literature DB >> 32948498

Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients.

Douglas J Conrad1, Joanne Billings2, Charlotte Teneback3, Jonathan Koff4, Daniel Rosenbluth5, Barbara A Bailey6, Raksha Jain7.   

Abstract

BACKGROUND: Cystic Fibrosis (CF) is a multi-systemic disorder resulting from genetic variation in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene which can result in bronchiectasis, chronic sinusitis, pancreatic malabsorption, cholestatic liver disease and distal intestinal obstructive syndrome. This study generates multi-dimensional clinical phenotypes that capture the complexity and spectrum of the disease manifestations seen in adult CF patients using statistically robust techniques.
METHODS: Pre-transplant clinical data from adult (age ≥18 years) CF patients (n = 992) seen in six regionally distinct US CF centers between 1/1/2014 and 6/30/2015 were included. Demographic, spirometry, nutritional, microbiological and therapy data were used to generate clusters using the Random Forests statistical-learning and Partitioning around Medoids (PAM) clustering algorithms. Five commonly measured demographic, physiological and nutritional parameters were needed to create the final phenotypes that are highly similar to a regionally matched group of patients from the CF Foundation Patient Registry
RESULTS: This approach identified high-risk phenotypes with expected characteristics including high rates of pancreatic insufficiency, diabetes and Pseudomonas aeruginosa colonization. It also identified unexpected populations including a) a male-dominated, well-nourished group with good lung function with a high prevalence of severe genotypes (i.e. 60% subjects had two minimal function CFTR variations), b) and an older, "survivor" phenotype that had high rates of chronic P. aeruginosa infection.
CONCLUSIONS: This study identified recognizable phenotypes that capture the clinical complexity in a statistically robust manner and which may aide in the identification of specific genetic and environmental factors responsible for these disease manifestation patterns.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2020        PMID: 32948498     DOI: 10.1016/j.jcf.2020.08.010

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  4 in total

1.  What Makes Pseudomonas aeruginosa a Pathogen?

Authors:  Burkhard Tümmler
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients.

Authors:  Anna Lisa Montemari; Valeria Marzano; Nour Essa; Stefano Levi Mortera; Martina Rossitto; Simone Gardini; Laura Selan; Gianluca Vrenna; Andrea Onetti Muda; Lorenza Putignani; Ersilia Vita Fiscarelli
Journal:  Front Med (Lausanne)       Date:  2022-03-09

3.  A machine learning approach using partitioning around medoids clustering and random forest classification to model groups of farms in regard to production parameters and bulk tank milk antibody status of two major internal parasites in dairy cows.

Authors:  Andreas W Oehm; Andrea Springer; Daniela Jordan; Christina Strube; Gabriela Knubben-Schweizer; Katharina Charlotte Jensen; Yury Zablotski
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

4.  Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.

Authors:  Thomas H Hampton; Devin Thomas; Christopher van der Gast; George A O'Toole; Bruce A Stanton
Journal:  Microbiol Spectr       Date:  2021-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.